Kristina Lantz

Kristina Lantz

Auto-generated profile, based on publicly available information

Kristina Lantz

National Veterinary Services Laboratories, Animal and Plant Health Inspection Services, United States Department of Agriculture, Ames, IA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025 in Science
Verified
Journal Article
Closed access
TNThao-Quyen Nguyen
Thao-Quyen Nguyen
CHCarl R. Hutter
Carl R. Hutter
AMAlexey Markin
Alexey Markin
MTMegan Thomas
Megan Thomas
KLKristina Lantz
Kristina Lantz
TATavis Anderson
Tavis Anderson
Highly pathogenic avian influenza (HPAI) viruses cross species barriers and have the potential to cause pandemics. In North America, HPAI A(H5N1) viruses related to the goose/Guangdong 2.3.4.4b hemagglutinin phylogenetic clade have infected wild birds, poultry, and mammals. Our genomic analysis and epidemiological investigation showed that a reassortment event in wild bird populations preceded a single wild bird–to-cattle transmission episode. The movement of asymptomatic or presymptomatic cattle has likely played a role in the spread of HPAI within the United States dairy herd. Some molecular markers that may lead to changes in transmission efficiency and phenotype were detected at low frequencies. Continued transmission of H5N1 HPAI within dairy cattle increases the risk for infection and subsequent spread of the virus to human populations.

15 October 2024 in Nature
Verified
Journal Article
Open access
PDF file
ABAmy L. Vincent Baker
Amy L. Vincent Baker
BABailey Arruda
Bailey Arruda
Mitchell V. PalmerMitchell V. Palmer
Mitchell V. Palmer
Paola M. BoggiattoPaola M. Boggiatto
Paola M. Boggiatto
KDKaitlyn Sarlo Davila
Kaitlyn Sarlo Davila
PGPatrick J. Gorden
Patrick J. Gorden
Highly pathogenic avian influenza (HPAI) H5N1 haemagglutinin clade 2.3.4.4b was detected in the USA in 2021. These HPAI viruses caused mortality events in poultry, wild birds and wild mammals. On 25 March 2024, HPAI H5N1 clade 2.3.4.4b was confirmed in a dairy cow in Texas in response to a multistate investigation into milk production losses1. More than 200 positive herds were identified in 14 US states. The case description included reduced feed intake and rumen motility in lactating cows, decreased milk production and thick yellow milk2,3. The diagnostic investigation revealed viral RNA in milk and alveolar epithelial degeneration and necrosis and positive immunoreactivity of glandular epithelium in mammary tissue. A single transmission event, probably from birds, was followed by limited local transmission and onward horizontal transmission of H5N1 clade 2.3.4.4b genotype B3.13 (ref. 4). Here we sought to experimentally reproduce infection with genotype B3.13 in Holstein yearling heifers and lactating cows. Heifers were inoculated by an aerosol respiratory route and cows by an intramammary route. Clinical disease was mild in heifers, but infection was confirmed by virus detection, lesions and seroconversion. Clinical disease in lactating cows included decreased rumen motility, changes to milk appearance and production losses. Infection was confirmed by high levels of viral RNA detected in milk, virus isolation, lesions in mammary tissue and seroconversion. This study provides the foundation to investigate additional routes of infection, pathogenesis, transmission and intervention strategies.

18 April 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
AMAllison Murawski
Allison Murawski
TFThomas Fabrizio
Thomas Fabrizio
RORobert J Ossiboff
Robert J Ossiboff
CKChristina Kackos
Christina Kackos
TJTrushar Jeevan
Trushar Jeevan
RWRichard J. Webby
Richard J. Webby
Since late 2021, highly pathogenic avian influenza (HPAI) viruses of A/goose/Guangdong/1/1996 (H5N1) lineage have caused widespread mortality in wild birds and poultry in the United States. Concomitant with the spread of HPAI viruses in birds are increasing numbers of mammalian infections, including wild and captive mesocarnivores and carnivores with central nervous system involvement. Here we report HPAI, A(H5N1) of clade 2.3.4.4b, in a common bottlenose dolphin (Tursiops truncatus) from Florida, United States. Pathological findings include neuronal necrosis and inflammation of the brain and meninges, and quantitative real time RT-PCR reveal the brain carried the highest viral load. Virus isolated from the brain contains a S246N neuraminidase substitution which leads to reduced inhibition by neuraminidase inhibitor oseltamivir. The increased prevalence of A(H5N1) viruses in atypical avian hosts and its cross-species transmission into mammalian species highlights the public health importance of continued disease surveillance and biosecurity protocols.

1 January 2022 in Veterinary Microbiology
Verified
Journal Article
Closed access
SHSamantha J. Hau
Samantha J. Hau
KLKristina Lantz
Kristina Lantz
KSKeira L. Stuart
Keira L. Stuart
PSPanchan Sitthicharoenchai
Panchan Sitthicharoenchai
NMNubia Macedo
Nubia Macedo
SBSusan L. Brockmeier
Susan L. Brockmeier

30 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
Wendy PuryearWendy Puryear
Wendy Puryear
KSKaitlin Sawatzki
Kaitlin Sawatzki
NHNichola Hill
Nichola Hill
AFAlexa Foss
Alexa Foss
JSJonathon J. Stone
Jonathon J. Stone
JRJonathan Runstadler
Jonathan Runstadler
The recent incursion of Highly Pathogenic Avian Influenza A (H5N1) virus into North America and subsequent dissemination of virus across the continent, has had significant adverse impacts on domestic poultry, and has led to widespread mortality in many wild bird species. Here we report the recent spillover of H5N1 into marine mammals in the northeastern United States, with associated mortality on a regional scale. This spillover is coincident with a second wave of H5N1 in sympatric wild birds also experiencing regional mortality events. Viral sequences derived from both seal and avian hosts reveal distinct viral genetic differences between the two waves of infection. Spillover into seals was closely related to virus from the second wave, and one of eight seal-derived sequences had the mammalian adaptation PB2 E627K. One-Sentence Summary An outbreak of H5N1 in New England seals is the first known population-scale mammalian mortality event associated with the emerging highly pathogenic avian influenza clade 2.3.4.4b.

4 October 2023 in Animals
Verified
Journal Article
Open access
PDF file
DTDeepanker Tewari
Deepanker Tewari
RMRyan Miller
Ryan Miller
JLJulia Livengood
Julia Livengood
Leyi WangLeyi Wang
Leyi Wang
MKMary Lea Killian
Mary Lea Killian
JRJustin Rosenberg
Justin Rosenberg
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported in multiple animal species besides humans. The goal of this study was to report clinical signs, infection progression, virus detection and antibody response in a group of wild felids housed in adjacent but neighboring areas at the Pittsburgh Zoo. Initially, five African lions (Panthera leo krugeri) housed together exhibited respiratory clinical signs with viral shedding in their feces in March of 2021 coinciding with infection of an animal keeper. During the second infection wave in December 2021, four Amur tigers (Panthera tigris altaica) and a Canadian lynx (Lynx canadensis) showed clinical signs and tested positive for viral RNA in feces. In infected animals, viral shedding in feces was variable lasting up to 5 weeks and clinical signs were observed for up to 4 weeks. Despite mounting an antibody response to initial exposure, lions exhibited respiratory clinical signs during the second infection wave, but none shed the virus in their feces. The lions were positive for alpha variant (B.1.1.7 lineage) during the first wave and the tiger and lynx were positive for delta variant (AY.25.1. lineage) during the second wave. The viruses recovered from felids were closely related to variants circulating in human populations at the time of the infection. Cheetahs (Acinonyx jubatus) in the park did not show either the clinical signs or the antibody response.